Laboratorio de Investigación en Agentes Antibacterianos (LIAA), Universidad de Concepción, Concepción 4070386, Chile.
Grupo de Estudio en Resistencia Antimicrobiana (GRAM), Universidad de Concepción, Concepción 4070386, Chile.
Genes (Basel). 2024 Sep 17;15(9):1213. doi: 10.3390/genes15091213.
has emerged as a significant human pathogen, acquiring multiple antibiotic resistance genes, including carbapenemases. This study focuses on characterizing the plasmids harboring the and (Y) genes in two carbapenem-resistant isolates (UCO-553 and UCO-554) obtained in Chile during the COVID-19 pandemic. : Antibiotic susceptibility testing was conducted on UCO-553 and UCO-554. Both isolates underwent whole-genome sequencing to ascertain their sequence type (ST), core genome multilocus sequence-typing (cgMLST) profile, antibiotic resistance genes, plasmids, and mobile genetic elements. Conjugation experiments were performed for both isolates. : Both isolates exhibited broad resistance, including resistance to carbapenems, third-generation cephalosporins, fluoroquinolones, tetracycline, cotrimoxazole, and aminoglycosides. Both isolates belong to sequence type ST1761, with a difference of 17 out of 2984 alleles. Each isolate carried a 47,274 bp plasmid with and genes and two highly similar plasmids: a 35,184 bp plasmid with (Y), , , and genes, and a 6078 bp plasmid containing the gene. Quinolone-resistance mutations were identified in the and genes of both isolates. Importantly, was located within a Tn transposon, and (Y) was embedded in a Tn transposon. Conjugation experiments successfully transferred and (Y) into the ATCC 19606 strain, indicating the potential for horizontal gene transfer. : This study highlights the critical role of plasmids in disseminating resistance genes in and underscores the need for the continued genomic surveillance of this emerging pathogen. The findings emphasize the importance of monitoring for its potential to cause difficult-to-treat infections and its capacity to spread resistance determinants against clinically significant antibiotics.
已成为重要的人类病原体,获得了多种抗生素耐药基因,包括碳青霉烯酶。本研究侧重于描述在智利 COVID-19 大流行期间获得的两株耐碳青霉烯的 (UCO-553 和 UCO-554)中携带 和 (Y) 基因的质粒。:对 UCO-553 和 UCO-554 进行了抗生素敏感性测试。对两种分离株进行了全基因组测序,以确定其序列类型(ST)、核心基因组多位点序列分型(cgMLST)谱、抗生素耐药基因、质粒和移动遗传元件。对两种分离株均进行了接合实验。:两种分离株均表现出广泛的耐药性,包括对碳青霉烯类、第三代头孢菌素类、氟喹诺酮类、四环素类、复方新诺明和氨基糖苷类的耐药性。两种分离株均属于序列类型 ST1761,2984 个等位基因中有 17 个不同。每个分离株都携带一个 47274bp 的质粒,带有 和 基因和两个高度相似的质粒:一个 35184bp 的质粒,带有 (Y)、 、 、 基因,和一个包含 基因的 6078bp 质粒。在两种分离株的 基因和 基因中都发现了喹诺酮耐药突变。重要的是, 位于 Tn 转座子内,而 (Y) 嵌入在 Tn 转座子内。接合实验成功地将 基因和 (Y) 转移到 ATCC 19606 菌株中,表明存在水平基因转移的潜力。:本研究强调了质粒在 传播耐药基因中的关键作用,并强调了对这种新兴病原体进行持续基因组监测的必要性。这些发现强调了监测 的重要性,因为它有可能引起难以治疗的感染,并具有传播对临床重要抗生素的耐药决定因素的能力。